Two new studies describe the benefits of the antiviral drugs nirmatrelvir-ritonavir (Paxlovid) and molnupiravir in reducing SARS-CoV-2 Omicron hospitalizations and death, with one finding that the former is more effective than the latter at lowering death rates.
U.S. COVID infections are hovering near levels of the pandemic’s first peak in 2020, and approaching the Delta peak of late 2021, according to wastewater surveillance and modeling by forecasters. ...
In a technical briefing on SARS-CoV-2 variants today, the UK Health Security Agency (HSA) revealed that, of 34 confirmed involving the highly mutated BA.2.86 variant, 28 were from a single outbreak at a nursing home, an early sign that it can spread in close-contact settings.
